actulose effects on intestinal probiotics and blood glucose in diabetic patients.
Not Applicable
- Conditions
- Type 2 diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT201210193565N7
- Lead Sponsor
- Research deputy of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
type II diabetes; age between 30 to 70 years; HbA1c 7 to 9.
Exclusion criteria: antibiotic use; presence of acute and chronic gastrointestinal diseases leading to intestinal dysfunction; HbA1c below 7 or above 9%; need to change medication or diet during the study; use of medications affecting bowel function such as drugs for peptic ulcers, probiotics, laxatives; no history of surgery on gastrointestinal tract and liver; the absence of other systemic diseases affecting the gastrointestinal tract such as uncontrolled hypothyroidism, renal failure, liver disease and advanced heart failure; lack of consent to participate in the study.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose levels. Timepoint: Baseline and three months after starting the study. Method of measurement: Paraclinical.;Hemoglobin A1C. Timepoint: Baseline and three months after starting the study. Method of measurement: Paraclinical.;Stool probiotic bactria count. Timepoint: Baseline and three months after starting the study. Method of measurement: Culture and colony count.
- Secondary Outcome Measures
Name Time Method